NuVasive Management Discusses Q2 2012 Results - Earnings Call Transcript

NuVasive (NUVA)

Q2 2012 Earnings Call

July 25, 2012 5:30 pm ET

Executives

Patrick F. Williams - Vice President of Finance & Investor Relations

Alexis V. Lukianov - Chairman and Chief Executive Officer

Michael J. Lambert - Chief Financial Officer, Principal Accounting Officer and Executive Vice President

Keith C. Valentine - President and Chief Operating Officer

Analysts

Matthew S. Miksic - Piper Jaffray Companies, Research Division

Raj Denhoy - Jefferies & Company, Inc., Research Division

William J. Plovanic - Canaccord Genuity, Research Division

Richard Newitter - Leerink Swann LLC, Research Division

Robert A. Hopkins - BofA Merrill Lynch, Research Division

Lawrence Biegelsen - Wells Fargo Securities, LLC, Research Division

John M. Putnam - Capstone Investments, Research Division

Christopher T. Pasquale - JP Morgan Chase & Co, Research Division

Glenn J. Novarro - RBC Capital Markets, LLC, Research Division

Matthew Taylor - Barclays Capital, Research Division

David H. Roman - Goldman Sachs Group Inc., Research Division

Denis Kelleher

Matthew O'Brien - William Blair & Company L.L.C., Research Division

Jacob Messina

Michael Matson - Mizuho Securities USA Inc., Research Division

Spencer Nam - ThinkEquity LLC, Research Division

Jeffrey D. Johnson - Robert W. Baird & Co. Incorporated, Research Division

Presentation

Operator

Greetings, and welcome to the NuVasive Inc. Second Quarter 2012 Earnings Release Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Patrick Williams, Vice President of Strategy and Investor Relations for NuVasive. Thank you, Mr. Williams, you may begin.

Patrick F. Williams

Thanks, operator. Welcome to NuVasive's Second Quarter 2012 Earnings Conference Call. NuVasive's senior management on the call today will be Alex Lukianov, Chairman and Chief Executive Officer; Keith Valentine, President and Chief Operating Officer; and Michael Lambert, Executive Vice President and Chief Financial Officer.

If you liked this article you might like

Biotech Movers: Cesca Up Strong After Securing CAR-T Cell Patent

Masimo's Stock Is a Great Buy Right Now

NXPI, AAPL, C: Jim Cramer's Views

Cramer: Demand Lifts Defense, Aerospace, Cyber-Security, Regional Bank Stocks

NuVasive (NUVA) Stock Tumbles on Q3 Revenue Miss, Outlook